Healthcare Sales & Marketing Network News: Halobetasol

Searching News Database: Halobetasol

HSMN NewsFeed - 21 Sep 2021
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 20 Dec 2019
Bausch Health Announces Resolution Of BRYHALI(R) (Halobetasol Propionate) Lotion, 0.01%, Intellectual Property Litigation With Glenmark
Biopharmaceuticals Dermatology Litigation

HSMN NewsFeed - 22 May 2019
FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 4 Apr 2019
Citius Pharmaceuticals Successfully Raises $5.3 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Nov 2018
Perrigo Announces Tentative FDA Approval For The First To File Generic Version Of Ultravate(R) Lotion 0.05%
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 26 Oct 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Biopharmaceuticals Dermatology Acquisitions

HSMN NewsFeed - 8 Oct 2018
Bausch Health's BRYHALI(TM) (halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
Biopharmaceuticals Dermatology FDA

Return to NewsFeed

Additional items found! 1

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 1 additional stories matching:
Halobetasol
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.